Polypharmacy and smoking as potentially modifiable risk factors associated with symptom severity in men with lower urinary tract symptoms in primary care: findings from the primus study
Author(s)
Type
Journal Article
Date Issued
2022-02-22
Date Acceptance
2022-01-02
Citation
European Urology Focus, 2022, 8, pp.8-10
ISSN
2405-4569
Publisher
Elsevier B.V.
Start Page
8
End Page
10
Journal / Book Title
European Urology Focus
Volume
8
Copyright Statement
© 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Identifier
https://www.sciencedirect.com/science/article/pii/S2405456922000013?via%3Dihub
Subjects
Humans
Lower Urinary Tract Symptoms
Male
Polypharmacy
Primary Health Care
Risk Factors
Smoking
Humans
Polypharmacy
Risk Factors
Smoking
Primary Health Care
Male
Lower Urinary Tract Symptoms
1103 Clinical Sciences
Notes
Funding Information: Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05). keywords: Polypharmacy, smoking, lower urinary tract symptoms, PriMUS
Publication Status
Published
Article Number
1
Date Publish Online
2022-01-20